Spyre Therapeutics (SYRE) Tax Provisions (2021 - 2025)
Spyre Therapeutics posted quarterly Tax Provisions of -$15000.0 for Q1 2025, down 146.88% year-on-year from $32000.0 in Q1 2024, and down 1600.0% on a QoQ basis from $1000.0 in Q4 2024.
Spyre Therapeutics (SYRE) has 5 years of Tax Provisions data on file, last reported at -$15000.0 in Q1 2025.
- For the quarter ending Q1 2025, Tax Provisions fell 146.88% year-over-year to -$15000.0; the trailing twelve-month figure through Dec 2025 stood at -$15000.0 (down 129.41% YoY), and the FY2025 full-year result was -$15000.0, down 129.41% from the prior year.
- Tax Provisions for Q1 2025 stood at -$15000.0, down from $1000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $92000.0 in Q2 2021 and bottomed at -$209000.0 in Q3 2022.
- The 5-year median for Tax Provisions is $9000.0 (2022), against an average of -$846.15.
- The widest annual swing landed in 2022, when Tax Provisions slumped 903.85%; it then soared 500.0% in 2024.
- A 5-year view of Tax Provisions shows it stood at $23000.0 in 2021, then jumped by 65.22% to $38000.0 in 2022, then tumbled by 92.11% to $3000.0 in 2023, then sank by 66.67% to $1000.0 in 2024, then plunged by 1600.0% to -$15000.0 in 2025.
- The last three Tax Provisions figures came in at -$15000.0 (Q1 2025), $1000.0 (Q4 2024), and $18000.0 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -11.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 221.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 216,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.66 Mn |
| 10 | Spyre Therapeutics | 5.55 Bn | 5.55 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -15,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 18,000.00 |
| Mar 31, 2024 | 32,000.00 |
| Sep 30, 2023 | 3,000.00 |
| Jun 30, 2023 | 7,000.00 |
| Mar 31, 2023 | -36,000.00 |
| Dec 31, 2022 | 38,000.00 |
| Sep 30, 2022 | -209,000.00 |
| Jun 30, 2022 | 9,000.00 |
| Dec 31, 2021 | 23,000.00 |
| Sep 30, 2021 | 26,000.00 |
| Jun 30, 2021 | 92,000.00 |